Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating ...

Scientists have developed a tool that can predict how bowel cancer adapts to treatment—helping researchers to design new ...

New study results position Nuvalent to bring forward what it claims is a differentiated treatment for ROS1-positive lung ...

Ipsen has expanded its oncology pipeline by licensing a T-cell engager (TCE) therapy from Paris-based start-up Biomunex for up to $610m.

J&J JNJ announced that the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) recommended granting label expansion ...

Cancer genomics is the study of the totality of DNA sequence and gene expression differences between tumour cells and normal host cells. It aims to understand the genetic basis of tumour cell ...

New Cancer Target Discovered. 06/17/2025. Searching For Hope: How Research Gave One Family A Chance to Celebrate Life After a Devastating Diagnosis. Contact Johns Hopkins Media Relations. The Newsroom ...